| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/18/2005 | CN1615846A Soft capsule containing bergenin and its preparing method |
| 05/18/2005 | CN1615842A Preparation for treating allergic rhinitis and asthma |
| 05/18/2005 | CN1615840A Sodium camsylate freeze-dried powder injection preparation and its preparing method |
| 05/18/2005 | CN1615833A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/18/2005 | CN1615831A Pseudoephedrine hydrochloride dripping pill |
| 05/18/2005 | CN1615827A Medicinal powder injection for respiratory system and preparing method |
| 05/18/2005 | CN1615826A Guaiamar dripping pill |
| 05/18/2005 | CN1202134C Polysaccharide compound having immune stimulating activity |
| 05/18/2005 | CN1202118C Adenosine derivatives |
| 05/18/2005 | CN1202103C Preparation method of red sageroot total phenolic acid |
| 05/18/2005 | CN1202096C 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |
| 05/18/2005 | CN1202081C Amidino and guanidino bita-azetidinone tryptase inhibitors |
| 05/18/2005 | CN1202068C Aspirin-triggered lipid mediators |
| 05/18/2005 | CN1201813C Medicine composition, preparing method thereof and its use preparing medicines for curing SARS and SARS-induced cardio-cerebro complication |
| 05/18/2005 | CN1201803C Chinese medicine powder for treating nasosinusitis |
| 05/18/2005 | CN1201793C Medicine composition for treatment of cough and asthma and preparation thereof |
| 05/18/2005 | CN1201786C Traditional Chinese medicine composition for curing child's dyspepsia and cough and its preparing method |
| 05/18/2005 | CN1201767C Chinese medicine composition for treating asthma and preparation method thereof |
| 05/18/2005 | CN1201758C Chinese medicine for treating silicosis |
| 05/18/2005 | CN1201756C Manufactruring process for medicinal atomization liquid for treating pharyngitis |
| 05/18/2005 | CN1201737C Application of cepharanthine in preparing medicine for resisting SARS virus |
| 05/18/2005 | CN1201732C Oral pharmaceutical forms of administration with a delayed action |
| 05/18/2005 | CN1201730C Treatment of emphysema using RAR selective retinoid agonists |
| 05/17/2005 | US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders |
| 05/17/2005 | US6894067 5-heteroatom-substituted pyrazoles |
| 05/17/2005 | US6894065 For therapy of thrombosis, platelet aggregation, coagulation, cancer, inflammatory diseases or respiratory diseases |
| 05/17/2005 | US6894061 Substituted dihydrophenanthridinesulfonamides |
| 05/17/2005 | US6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes |
| 05/17/2005 | US6894036 4-dedimethylaminotetracycline derivatives |
| 05/17/2005 | US6893858 Human kcnq5 potassium channel, methods and compositions thereof |
| 05/17/2005 | US6893843 Nucleic acids |
| 05/17/2005 | US6893628 Aerosol formulations containing P134a and particulate medicament |
| 05/17/2005 | CA2335492C Pyrrolo[2,3-d]pyrimidine compounds |
| 05/17/2005 | CA2305256C Mometasone furoate suspensions for nebulization |
| 05/12/2005 | WO2005042727A2 Methods of organ regeneration |
| 05/12/2005 | WO2005041858A2 Mucin production inhibitor |
| 05/12/2005 | WO2005016514A3 Combinatorial synthesis on support |
| 05/12/2005 | WO2005009343A3 A1 adenosine receptor antogonists |
| 05/12/2005 | WO2005007699A3 Human antibody molecules for il-13 |
| 05/12/2005 | WO2005002572A3 Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 05/12/2005 | WO2003070903A3 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/12/2005 | US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate |
| 05/12/2005 | US20050101778 A2B adenosine receptor antagonists |
| 05/12/2005 | US20050101664 Anionically coupling an acyl imidazoyl carbamate with a primary amide or carbamate; N-alkylation; inosine-5*-monophosphate dehydrogenase inhibitors |
| 05/12/2005 | US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/12/2005 | US20050101635 Delivering to an external portion of the body passageway of a patient in need of a therapeutically effective amount of an antihistamine or decongestant to treat inflammatory diseases |
| 05/12/2005 | US20050101634 Bis(5-aeyl-2-pyridyl) derivatives |
| 05/12/2005 | US20050101615 Pyridopyrimidine or naphthyridine derivative |
| 05/12/2005 | US20050101612 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases |
| 05/12/2005 | US20050101591 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 05/12/2005 | US20050101575 Vitamin d3 derivatives and remedies using the same |
| 05/12/2005 | US20050101563 Using cyclooxygenase inhbitor and fatty acid; analgesics; antiinflammatory agents; antiarthritic agents; vision defects; urogenital disorders; gastrointestinal disorders |
| 05/12/2005 | US20050101557 Immunostimulatory nucleic acid molecules |
| 05/12/2005 | US20050101554 Methods for treating and preventing infectious disease |
| 05/12/2005 | US20050101529 Protein modification and maintenance molecules |
| 05/12/2005 | US20050100902 5-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptors |
| 05/12/2005 | US20050100894 Novel mitogen activated kinase |
| 05/12/2005 | US20050100616 Administering plant extracts; health food; allergies |
| 05/12/2005 | US20050100540 Platelet-activating factor acetylhydrolase |
| 05/12/2005 | CA2544377A1 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 05/12/2005 | CA2544357A1 Tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same |
| 05/12/2005 | CA2544352A1 Crystalline anhydrate with anticholinergic effect |
| 05/12/2005 | CA2544348A1 Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same |
| 05/12/2005 | CA2543745A1 Methods of organ regeneration |
| 05/12/2005 | CA2543080A1 Compositions and methods for activating innate and allergic immunity |
| 05/12/2005 | CA2542530A1 Pharmaceutical aerosol compositions |
| 05/11/2005 | EP1529053A2 Macrolide compounds endowed with antiinflammatory activity |
| 05/11/2005 | EP1529049A2 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 05/11/2005 | EP1529046A1 Substituted benzimidazole compounds |
| 05/11/2005 | EP1529040A1 Endiandric acid h derivatives as c-maf inhibitors for using against asthma |
| 05/11/2005 | EP1529038A1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 05/11/2005 | EP1529037A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 05/11/2005 | EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 05/11/2005 | EP1399127B1 Olopatadine formulations for topical administration |
| 05/11/2005 | EP1397363B1 5-ethyl-imidazotriazinones |
| 05/11/2005 | EP1254138B1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 05/11/2005 | EP1147087B1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
| 05/11/2005 | EP0861071B1 Benzamidoxime prodrugs and use thereof for treating pneumonia |
| 05/11/2005 | CN2698345Y Mango containing cough-relieving capsule |
| 05/11/2005 | CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor |
| 05/11/2005 | CN1615309A Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 05/11/2005 | CN1615134A Pharmaceutical compositions comprising valsartan and NEP inhibitors |
| 05/11/2005 | CN1614030A Gene artificial synthesis and SARS virus protective antigen-amino acid series |
| 05/11/2005 | CN1613870A Tetramer combined with SARS antigen peptide and its preparation and use |
| 05/11/2005 | CN1613486A Composite cottonrose hibiscus and mongolia bark drop pellets and their preparation |
| 05/11/2005 | CN1613485A Iron-sheet dendrobe compound drop pellets and their preparation |
| 05/11/2005 | CN1613483A Cold preventing medicine |
| 05/11/2005 | CN1613456A Freezing dried mycobatctericsis preparation and its preparing method and use |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/11/2005 | CN1200932C Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 05/11/2005 | CN1200726C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 05/11/2005 | CN1200713C New (aminopropyl) methylphosphinic acids |
| 05/11/2005 | CN1200709C Dextromethorphan hydrobromide drop pills and preparation process thereof |
| 05/11/2005 | CN1200706C Compositions and methods for treating or preventing inflammatory diseases |
| 05/11/2005 | CN1200704C Appliance of probucol monoesters for treatment of cardiovascular and inflammatory disease |
| 05/11/2005 | CN1200700C Pharmaceutical tramadol salts |
| 05/10/2005 | US6890959 Such as cis-(4-dimethylaminomethyl-3-hydroxy-3-(3-methoxy-phenyl)-cyclohexanone for treatment of pain, inflammation, allergies, depression, drug/alcohol abuse, gastritis, itching, cardiovascular/repiratory diseases, epilepsy, and diarrhea |
| 05/10/2005 | US6890939 Aminopyrrolidine sulfonamides as serine protease inhibitors |
| 05/10/2005 | US6890938 Antiinflammatory agents |